San Diego , CA 92109 Location map
Hilton San Diego Resort
New Advances in Inflammatory Bowel Disease
Crohn’s disease and ulcerative colitis, collectively known as Inflammatory Bowel Disease (IBD), are considered chronic and lifelong conditions that are characterized by alternating periods of active symptomatic disease and periods of remission. IBD is one of the five most prevalent gastrointestinal disease burdens in the United States, with an overall health care cost of more than $1.7 billion and it is estimated that more than one million people in the United States are affected by the disease. Because IBD is a lifelong condition, the importance of establishing and maintaining symptom control and remission is critical to minimizing complications. The treatment of active IBD has improved considerably, but a high rate of relapse is still associated with the disease, and maintaining remission can prove challenging to providers.
Contact the event managers listed below for more information about how you can participate at the New Advances in Inflammatory Bowel Disease.
internists, colorectal surgeons and allied health professionals involved in the care of patients with Inflammatory Bowel Disease (IBD).
Exhibitor Information +